In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer’s disease

Sanchez-Rodriguez, Lazaro M.; Khan, Ahmed F.; Adewale, Quadri; Bezgin, Gleb; Therriault, Joseph; Fernandez-Arias, Jaime; Servaes, Stijn; Rahmouni, Nesrine; Tissot, Cécile; Stevenson, Jenna; Jiang, Hongxiu; Chai, Xiaoqian; Carbonell, Felix; Rosa-Neto, Pedro; Iturria-Medina, Yasser

doi:10.3389/fnagi.2024.1383163

In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer’s disease

Journal Article · Tue Jun 18 00:00:00 EDT 2024 · Frontiers in aging neuroscience

DOI:https://doi.org/10.3389/fnagi.2024.1383163· OSTI ID:2405929

Sanchez-Rodriguez, Lazaro M. ^[1]; Khan, Ahmed F. ^[1]; Adewale, Quadri ^[1]; Bezgin, Gleb ^[2]; Therriault, Joseph ^[3]; Fernandez-Arias, Jaime ^[3]; Servaes, Stijn ^[3]; Rahmouni, Nesrine ^[3]; Tissot, Cécile ^[4]; Stevenson, Jenna ^[3]; Jiang, Hongxiu ^[5]; Chai, Xiaoqian ^[5]; Carbonell, Felix ^[6]; Rosa-Neto, Pedro ^[3]; Iturria-Medina, Yasser ^[1]

McGill University, Montreal, QC (Canada); McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, QC (Canada); Ludmer Centre for Neuroinformatics and Mental Health, Montreal, QC (Canada)
McGill University, Montreal, QC (Canada); McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, QC (Canada); Ludmer Centre for Neuroinformatics and Mental Health, Montreal, QC (Canada); McGill University Research Centre for Studies in Aging, Douglas Research Centre, Montreal, QC (Canada)
McGill University, Montreal, QC (Canada); McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, QC (Canada); McGill University Research Centre for Studies in Aging, Douglas Research Centre, Montreal, QC (Canada)
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States); McGill University, Montreal, QC (Canada); McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, QC (Canada); McGill University Research Centre for Studies in Aging, Douglas Research Centre, Montreal, QC (Canada)
McGill University, Montreal, QC (Canada); McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, QC (Canada)
Biospective Inc., Montreal, QC (Canada)

The molecular mechanisms underlying neuronal dysfunction in Alzheimer’s disease (AD) remain uncharacterized. Here, we identify genes, molecular pathways and cellular components associated with whole-brain dysregulation caused by amyloid-beta (Aβ) and tau deposits in the living human brain. We obtained in-vivo resting-state functional MRI (rs-fMRI), Aβ- and tau-PET for 47 cognitively unimpaired and 16 AD participants from the Translational Biomarkers in Aging and Dementia cohort. Adverse neuronal activity impacts by Aβ and tau were quantified with personalized dynamical models by fitting pathology-mediated computational signals to the participant’s real rs-fMRIs. Then, we detected robust brain-wide associations between the spatial profiles of Aβ-tau impacts and gene expression in the neurotypical transcriptome (Allen Human Brain Atlas). Within the obtained distinctive signature of in-vivo neuronal dysfunction, several genes have prominent roles in microglial activation and in interactions with Aβ and tau. Moreover, cellular vulnerability estimations revealed strong association of microglial expression patterns with Aβ and tau’s synergistic impact on neuronal activity (q < 0.001). These results further support the central role of the immune system and neuroinflammatory pathways in AD pathogenesis. Neuronal dysregulation by AD pathologies also associated with neurotypical synaptic and developmental processes. In addition, we identified drug candidates from the vast LINCS library to halt or reduce the observed Aβ-tau effects on neuronal activity. Top-ranked pharmacological interventions target inflammatory, cancer and cardiovascular pathways, including specific medications undergoing clinical evaluation in AD. Our findings, based on the examination of molecular-pathological-functional interactions in humans, may accelerate the process of bringing effective therapies into clinical practice.

View Accepted Manuscript (DOE)

Research Organization:: Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)

Sponsoring Organization:: USDOE Office of Science (SC)

Grant/Contract Number:: AC02-05CH11231

OSTI ID:: 2405929

Journal Information:: Frontiers in aging neuroscience, Journal Name: Frontiers in aging neuroscience Vol. 16; ISSN 1663-4365

Publisher:: FrontiersCopyright Statement

Country of Publication:: United States

Language:: English

References (97)

Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease Quinn, Joseph F.; Raman, Rema; Thomas, Ronald G. JAMA, Vol. 304, Issue 17 https://doi.org/10.1001/jama.2010.1510	journal	November 2010
Blood Leukocyte Counts in Alzheimer Disease Luo, Jiao; Thomassen, Jesper Qvist; Nordestgaard, Børge G. JAMA Network Open, Vol. 5, Issue 10 https://doi.org/10.1001/jamanetworkopen.2022.35648	journal	October 2022
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease Howard, Robert; Zubko, Olga; Bradley, Rosie JAMA Neurology, Vol. 77, Issue 2 https://doi.org/10.1001/jamaneurol.2019.3762	journal	February 2020
Getting Started with LINCS Datasets and Tools Xie, Zhuorui; Kropiwnicki, Eryk; Wojciechowicz, Megan L. Current Protocols, Vol. 2, Issue 7 https://doi.org/10.1002/cpz1.487	journal	July 2022
Model driven EEG/fMRI fusion of brain oscillations Valdes‐Sosa, Pedro A.; Sanchez‐Bornot, Jose Miguel; Sotero, Roberto Carlos Human Brain Mapping, Vol. 30, Issue 9 https://doi.org/10.1002/hbm.20704	journal	December 2008
A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy Gadhave, Kundlik; Kumar, Deepak; Uversky, Vladimir N. Medicinal Research Reviews, Vol. 41, Issue 5 https://doi.org/10.1002/med.21719	journal	August 2020
Alzheimer's disease drug development pipeline: 2021 Cummings, Jeffrey; Lee, Garam; Zhong, Kate Alzheimer's & Dementia: Translational Research & Clinical Interventions, Vol. 7, Issue 1 https://doi.org/10.1002/trc2.12179	journal	January 2021
Retinal pathological features and proteome signatures of Alzheimer’s disease Koronyo, Yosef; Rentsendorj, Altan; Mirzaei, Nazanin Acta Neuropathologica, Vol. 145, Issue 4 https://doi.org/10.1007/s00401-023-02548-2	journal	February 2023
Repurposing drugs against Alzheimer’s disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD? Leßmann, Volkmar; Kartalou, Georgia-Ioanna; Endres, Thomas Journal of Neural Transmission, Vol. 130, Issue 8 https://doi.org/10.1007/s00702-023-02618-5	journal	April 2023
Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations Koizumi, Kenzo; Wang, Gang; Park, Laibaik Cellular and Molecular Neurobiology, Vol. 36, Issue 2 https://doi.org/10.1007/s10571-015-0256-9	journal	September 2015
Frequency-dependent changes in fractional amplitude of low-frequency oscillations in Alzheimer’s disease: a resting-state fMRI study Yang, Liu; Yan, Yan; Li, Yuxia Brain Imaging and Behavior, Vol. 14, Issue 6 https://doi.org/10.1007/s11682-019-00169-6	journal	September 2019
Excitatory and Inhibitory Interactions in Localized Populations of Model Neurons Wilson, Hugh R.; Cowan, Jack D. Biophysical Journal, Vol. 12, Issue 1 https://doi.org/10.1016/S0006-3495(72)86068-5	journal	January 1972
Epileptic activity in Alzheimer's disease: causes and clinical relevance Vossel, Keith A.; Tartaglia, Maria C.; Nygaard, Haakon B. The Lancet Neurology, Vol. 16, Issue 4 https://doi.org/10.1016/S1474-4422(17)30044-3	journal	April 2017
Neuronal excitation/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology Maestú, Fernando; de Haan, Willem; Busche, Marc Aurel Ageing Research Reviews, Vol. 69 https://doi.org/10.1016/j.arr.2021.101372	journal	August 2021
A Multimodal Meta-Analytical Evidence of Functional and Structural Brain Abnormalities Across Alzheimer's Disease Spectrum Tang, Xinyue; Guo, Zixuan; Chen, Guanmao Ageing Research Reviews, Vol. 95 https://doi.org/10.1016/j.arr.2024.102240	journal	March 2024
SYK coordinates neuroprotective microglial responses in neurodegenerative disease Ennerfelt, Hannah; Frost, Elizabeth L.; Shapiro, Daniel A. Cell, Vol. 185, Issue 22 https://doi.org/10.1016/j.cell.2022.09.030	journal	October 2022
Single-neuron models linking electrophysiology, morphology, and transcriptomics across cortical cell types Nandi, Anirban; Chartrand, Thomas; Van Geit, Werner Cell Reports, Vol. 40, Issue 6 https://doi.org/10.1016/j.celrep.2022.111176	journal	August 2022
Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD Deco, Gustavo; Cruzat, Josephine; Cabral, Joana Current Biology, Vol. 28, Issue 19 https://doi.org/10.1016/j.cub.2018.07.083	journal	October 2018
Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial Arellanes, Isabella C.; Choe, Nicholas; Solomon, Victoria eBioMedicine, Vol. 59 https://doi.org/10.1016/j.ebiom.2020.102883	journal	September 2020
Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies Annadurai, Narendran; De Sanctis, Juan B.; Hajdúch, Marián Experimental Neurology, Vol. 343 https://doi.org/10.1016/j.expneurol.2021.113756	journal	September 2021
Association of cancer and Alzheimer's disease risk in a national cohort of veterans Frain, Laura; Swanson, David; Cho, Kelly Alzheimer's & Dementia, Vol. 13, Issue 12 https://doi.org/10.1016/j.jalz.2017.04.012	journal	July 2017
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease Jack, Clifford R.; Bennett, David A.; Blennow, Kaj Alzheimer's & Dementia, Vol. 14, Issue 4 https://doi.org/10.1016/j.jalz.2018.02.018	journal	April 2018
Activation of NOD2/RIPK2 pathway induces mitochondrial injury to oligodendrocyte precursor cells in vitro and CNS demyelination in vivo Natarajan, Chandramohan; Yao, Song-Yi; Zhang, Fanglin Journal of Neuroimmunology, Vol. 265, Issue 1-2 https://doi.org/10.1016/j.jneuroim.2013.09.009	journal	December 2013
Modelling the role of excitatory and inhibitory neuronal activity in the generation of the BOLD signal Sotero, Roberto C.; Trujillo-Barreto, Nelson J. NeuroImage, Vol. 35, Issue 1 https://doi.org/10.1016/j.neuroimage.2006.10.027	journal	March 2007
Characterizing brain anatomical connections using diffusion weighted MRI and graph theory Iturria-Medina, Y.; Canales-Rodríguez, E. J.; Melie-García, L. NeuroImage, Vol. 36, Issue 3 https://doi.org/10.1016/j.neuroimage.2007.02.012	journal	July 2007
A fast diffeomorphic image registration algorithm Ashburner, John NeuroImage, Vol. 38, Issue 1 https://doi.org/10.1016/j.neuroimage.2007.07.007	journal	October 2007
Biophysical model for integrating neuronal activity, EEG, fMRI and metabolism Sotero, Roberto C.; Trujillo-Barreto, Nelson J. NeuroImage, Vol. 39, Issue 1 https://doi.org/10.1016/j.neuroimage.2007.08.001	journal	January 2008
Resolving crossing fibres using constrained spherical deconvolution: Validation using diffusion-weighted imaging phantom data Tournier, J. -Donald; Yeh, Chun-Hung; Calamante, Fernando NeuroImage, Vol. 42, Issue 2 https://doi.org/10.1016/j.neuroimage.2008.05.002	journal	August 2008
Spatial analysis and high resolution mapping of the human whole-brain transcriptome for integrative analysis in neuroimaging Gryglewski, Gregor; Seiger, René; James, Gregory Miles NeuroImage, Vol. 176 https://doi.org/10.1016/j.neuroimage.2018.04.068	journal	August 2018
Multimodal imaging-based therapeutic fingerprints for optimizing personalized interventions: Application to neurodegeneration Iturria-Medina, Yasser; Carbonell, Félix M.; Evans, Alan C. NeuroImage, Vol. 179 https://doi.org/10.1016/j.neuroimage.2018.06.028	journal	October 2018
Detecting brain network communities: Considering the role of information flow and its different temporal scales Sanchez-Rodriguez, Lazaro M.; Iturria-Medina, Yasser; Mouches, Pauline NeuroImage, Vol. 225 https://doi.org/10.1016/j.neuroimage.2020.117431	journal	January 2021
RESTplus: an improved toolkit for resting-state functional magnetic resonance imaging data processing Jia, Xi-Ze; Wang, Jue; Sun, Hai-Yang Science Bulletin, Vol. 64, Issue 14 https://doi.org/10.1016/j.scib.2019.05.008	journal	July 2019
Interneuron Accumulation of Phosphorylated tau Impairs Adult Hippocampal Neurogenesis by Suppressing GABAergic Transmission Zheng, Jie; Li, Hong-Lian; Tian, Na Cell Stem Cell, Vol. 26, Issue 3 https://doi.org/10.1016/j.stem.2019.12.015	journal	March 2020
Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer’s Disease: Using the Multiomics Approach Advani, Dia; Kumar, Pravir ACS Omega, Vol. 6, Issue 21 https://doi.org/10.1021/acsomega.1c01526	journal	May 2021
An anatomically comprehensive atlas of the adult human brain transcriptome Hawrylycz, Michael J.; Lein, Ed S.; Guillozet-Bongaarts, Angela L. Nature, Vol. 489, Issue 7416 https://doi.org/10.1038/nature11405	journal	September 2012
Transcriptomic analysis of purified human cortical microglia reveals age-associated changes Galatro, Thais F.; Holtman, Inge R.; Lerario, Antonio M. Nature Neuroscience, Vol. 20, Issue 8 https://doi.org/10.1038/nn.4597	journal	July 2017
Drug repositioning for Alzheimer's disease Corbett, Anne; Pickett, James; Burns, Alistair Nature Reviews Drug Discovery, Vol. 11, Issue 11 https://doi.org/10.1038/nrd3869	journal	November 2012
Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype? Targa Dias Anastacio, Helena; Matosin, Natalie; Ooi, Lezanne Translational Psychiatry, Vol. 12, Issue 1 https://doi.org/10.1038/s41398-022-02024-7	journal	June 2022
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets Zhou, Yingyao; Zhou, Bin; Pache, Lars Nature Communications, Vol. 10, Issue 1 https://doi.org/10.1038/s41467-019-09234-6	journal	April 2019
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease Vogel, Jacob W.; Iturria-Medina, Yasser; Strandberg, Olof T. Nature Communications, Vol. 11, Issue 1 https://doi.org/10.1038/s41467-020-15701-2	journal	May 2020
Machine learning identifies candidates for drug repurposing in Alzheimer’s disease Rodriguez, Steve; Hug, Clemens; Todorov, Petar Nature Communications, Vol. 12, Issue 1 https://doi.org/10.1038/s41467-021-21330-0	journal	February 2021
Synergy between amyloid-β and tau in Alzheimer’s disease Busche, Marc Aurel; Hyman, Bradley T. Nature Neuroscience, Vol. 23, Issue 10 https://doi.org/10.1038/s41593-020-0687-6	journal	August 2020
A curated diverse molecular database of blood-brain barrier permeability with chemical descriptors Meng, Fanwang; Xi, Yang; Huang, Jinfeng Scientific Data, Vol. 8, Issue 1 https://doi.org/10.1038/s41597-021-01069-5	journal	October 2021
Multivariate genomic and transcriptomic determinants of imaging-derived personalized therapeutic needs in Parkinson’s disease Lenglos, Christophe; Lin, Sue-Jin; Zeighami, Yashar Scientific Reports, Vol. 12, Issue 1 https://doi.org/10.1038/s41598-022-09506-0	journal	March 2022
Integrating molecular, histopathological, neuroimaging and clinical neuroscience data with NeuroPM-box Iturria-Medina, Yasser; Carbonell, Félix; Assadi, Atousa Communications Biology, Vol. 4, Issue 1 https://doi.org/10.1038/s42003-021-02133-x	journal	May 2021
Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer’s disease Sanchez-Rodriguez, Lazaro M.; Bezgin, Gleb; Carbonell, Felix Communications Biology, Vol. 7, Issue 1 https://doi.org/10.1038/s42003-024-06217-2	journal	May 2024
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging Therriault, Joseph; Pascoal, Tharick A.; Lussier, Firoza Z. Nature Aging, Vol. 2, Issue 6 https://doi.org/10.1038/s43587-022-00204-0	journal	April 2022
Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer’s disease Bennett, Rachel E.; Robbins, Ashley B.; Hu, Miwei Proceedings of the National Academy of Sciences, Vol. 115, Issue 6 https://doi.org/10.1073/pnas.1710329115	journal	January 2018
18F-MK-6240 PET for early and late detection of neurofibrillary tangles Pascoal, Tharick A.; Therriault, Joseph; Benedet, Andrea L. Brain, Vol. 143, Issue 9 https://doi.org/10.1093/brain/awaa180	journal	July 2020
Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease Khan, Ahmed Faraz; Adewale, Quadri; Baumeister, Tobias R. Brain, Vol. 145, Issue 5 https://doi.org/10.1093/brain/awab375	journal	October 2021
Blood and brain gene expression trajectories mirror neuropathology and clinical deterioration in neurodegeneration Iturria-Medina, Yasser; Khan, Ahmed F.; Adewale, Quadri Brain, Vol. 143, Issue 2 https://doi.org/10.1093/brain/awz400	journal	January 2020
Anti-inflammatories in Alzheimer’s disease—potential therapy or spurious correlate? Rivers-Auty, Jack; Mather, Alison E.; Peters, Ruth Brain Communications, Vol. 2, Issue 2 https://doi.org/10.1093/braincomms/fcaa109	journal	July 2020
In Alzheimer-prone brain regions, metabolism and risk-gene expression are strongly correlated Ye, Fengdan; Funk, Quentin; Rockers, Elijah Brain Communications, Vol. 4, Issue 5 https://doi.org/10.1093/braincomms/fcac216	journal	August 2022
SigCom LINCS: data and metadata search engine for a million gene expression signatures Evangelista, John Erol; Clarke, Daniel J. B.; Xie, Zhuorui Nucleic Acids Research, Vol. 50, Issue W1 https://doi.org/10.1093/nar/gkac328	journal	May 2022
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants Piñero, Janet; Bravo, Àlex; Queralt-Rosinach, Núria Nucleic Acids Research, Vol. 45, Issue D1 https://doi.org/10.1093/nar/gkw943	journal	October 2016
Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration Mandelkow, E. -M.; Mandelkow, E. Cold Spring Harbor Perspectives in Medicine, Vol. 2, Issue 7 https://doi.org/10.1101/cshperspect.a006247	journal	March 2012
CD33 in Alzheimer’s Disease – Biology, Pathogenesis, and Therapeutics: A Mini-Review Zhao, Lingzhi Gerontology, Vol. 65, Issue 4 https://doi.org/10.1159/000492596	journal	December 2018
Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population‐Based Cohort Study Bezabhe, Woldesellassie M.; Bereznicki, Luke R.; Radford, Jan Journal of the American Heart Association, Vol. 11, Issue 7 https://doi.org/10.1161/JAHA.121.023098	journal	April 2022
Alzheimer’s disease: risk factors and potentially protective measures Silva, Marcos Vinícius Ferreira; Loures, Cristina de Mello Gomide; Alves, Luan Carlos Vieira Journal of Biomedical Science, Vol. 26, Issue 1 https://doi.org/10.1186/s12929-019-0524-y	journal	May 2019
Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease Newcombe, Estella A.; Camats-Perna, Judith; Silva, Mallone L. Journal of Neuroinflammation, Vol. 15, Issue 1 https://doi.org/10.1186/s12974-018-1313-3	journal	September 2018
α-synuclein in the pathophysiology of Alzheimer’s disease Twohig, Daniel; Nielsen, Henrietta M. Molecular Neurodegeneration, Vol. 14, Issue 1 https://doi.org/10.1186/s13024-019-0320-x	journal	June 2019
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics Zetterberg, Henrik; Blennow, Kaj Molecular Neurodegeneration, Vol. 16, Issue 1 https://doi.org/10.1186/s13024-021-00430-x	journal	February 2021
The neuroimmune axis of Alzheimer’s disease Jorfi, Mehdi; Maaser-Hecker, Anna; Tanzi, Rudolph E. Genome Medicine, Vol. 15, Issue 1 https://doi.org/10.1186/s13073-023-01155-w	journal	January 2023
Antiherpetic drugs: a potential way to prevent Alzheimer’s disease? Linard, Morgane; Bezin, Julien; Hucteau, Emilie Alzheimer's Research & Therapy, Vol. 14, Issue 1 https://doi.org/10.1186/s13195-021-00950-0	journal	January 2022
A multiscale brain network model links Alzheimer’s disease-mediated neuronal hyperactivity to large-scale oscillatory slowing van Nifterick, Anne M.; Gouw, Alida A.; van Kesteren, Ronald E. Alzheimer's Research & Therapy, Vol. 14, Issue 1 https://doi.org/10.1186/s13195-022-01041-4	journal	July 2022
Modeling Focal Epileptic Activity in the Wilson–Cowan Model with Depolarization Block Meijer, Hil G. E.; Eissa, Tahra L.; Kiewiet, Bert The Journal of Mathematical Neuroscience (JMN), Vol. 5, Issue 1 https://doi.org/10.1186/s13408-015-0019-4	journal	March 2015
Voxel-based meta-analysis of grey matter changes in Alzheimer’s disease Wang, Wen-Ying; Yu, Jin-Tai; Liu, Yong Translational Neurodegeneration, Vol. 4, Issue 1 https://doi.org/10.1186/s40035-015-0027-z	journal	March 2015
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes Kwon, Hyuk Sung; Koh, Seong-Ho Translational Neurodegeneration, Vol. 9, Issue 1 https://doi.org/10.1186/s40035-020-00221-2	journal	November 2020
Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer’s Disease Tok, S.; Maurin, H.; Delay, C. Acta Neuropathologica Communications, Vol. 10, Issue 1 https://doi.org/10.1186/s40478-022-01393-w	journal	June 2022
Design of optimal nonlinear network controllers for Alzheimer's disease Sanchez-Rodriguez, Lazaro M.; Iturria-Medina, Yasser; Baines, Erica A. PLOS Computational Biology, Vol. 14, Issue 5 https://doi.org/10.1371/journal.pcbi.1006136	journal	May 2018
Cancer and Neurodegeneration: Between the Devil and the Deep Blue Sea Plun-Favreau, Hélène; Lewis, Patrick A.; Hardy, John PLoS Genetics, Vol. 6, Issue 12 https://doi.org/10.1371/journal.pgen.1001257	journal	December 2010
An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations Mullen, Joseph; Cockell, Simon J.; Woollard, Peter PLOS ONE, Vol. 11, Issue 5 https://doi.org/10.1371/journal.pone.0155811	journal	May 2016
Senolytic Therapy to Modulate the Progression of Alzheimer’s Disease (SToMP-AD): A Pilot Clinical Trial Gonzales, M. M.; Garbarino, V. R.; Marques Zilli, E. The Journal of Prevention of Alzheimer's Disease https://doi.org/10.14283/jpad.2021.62	journal	January 2021
The Effect of Annexin A1 as a Potential New Therapeutic Target on Neuronal Damage by Activated Microglia You, Ji-Eun; Jung, Se-Hwa; Kim, Pyung-Hwan Molecules and Cells, Vol. 44, Issue 4 https://doi.org/10.14348/MOLCELLS.2021.0020	journal	April 2021
Homeostatic Activity-Dependent Tuning of Recurrent Networks for Robust Propagation of Activity Gjorgjieva, Julijana; Evers, Jan Felix; Eglen, Stephen J. The Journal of Neuroscience, Vol. 36, Issue 13 https://doi.org/10.1523/JNEUROSCI.2511-15.2016	journal	March 2016
NM101 Phase III Study of NE3107 in Alzheimer’s Disease: rationale, Design and Therapeutic Modulation of Neuroinflammation and Insulin Resistance Reading, Christopher L.; Ahlem, Clarence N.; Murphy, Michael F. Neurodegenerative Disease Management, Vol. 11, Issue 4 https://doi.org/10.2217/nmt-2021-0022	journal	July 2021
Determining Amyloid-β Positivity Using ¹⁸F-AZD4694 PET Imaging Therriault, Joseph; Benedet, Andrea L.; Pascoal, Tharick A. Journal of Nuclear Medicine, Vol. 62, Issue 2 https://doi.org/10.2967/jnumed.120.245209	journal	July 2020
Cortical Sources of Resting State EEG Rhythms are Sensitive to the Progression of Early Stage Alzheimer's Disease Babiloni, Claudio; Lizio, Roberta; Del Percio, Claudio Journal of Alzheimer's Disease, Vol. 34, Issue 4 https://doi.org/10.3233/JAD-121750	journal	March 2013
Selected Findings from the Religious Orders Study and Rush Memory and Aging Project Bennett, David A.; Wilson, Robert S.; Arvanitakis, Zoe Journal of Alzheimer's Disease, Vol. 33, Issue s1 https://doi.org/10.3233/JAD-2012-129007	journal	December 2012
Revisiting the Relationship Between Alzheimer’s Disease and Cancer With a circRNA Perspective Chen, Danze; Hao, Shijia; Xu, Jianzhen Frontiers in Cell and Developmental Biology, Vol. 9 https://doi.org/10.3389/fcell.2021.647197	journal	March 2021
Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer’s Disease Shen, Zhiwei; Bao, Xinjie; Wang, Renzhi Frontiers in Aging Neuroscience, Vol. 10 https://doi.org/10.3389/fnagi.2018.00314	journal	October 2018
Most Pathways Can Be Related to the Pathogenesis of Alzheimer’s Disease Morgan, Sarah L.; Naderi, Pourya; Koler, Katjuša Frontiers in Aging Neuroscience, Vol. 14 https://doi.org/10.3389/fnagi.2022.846902	journal	June 2022
Integrated analysis and identification of hub genes as novel biomarkers for Alzheimer’s disease Zhao, Kun; Zhang, Hui; Wu, Yinyan Frontiers in Aging Neuroscience, Vol. 14 https://doi.org/10.3389/fnagi.2022.901972	journal	August 2022
Linking Molecular Pathways and Large-Scale Computational Modeling to Assess Candidate Disease Mechanisms and Pharmacodynamics in Alzheimer's Disease Stefanovski, Leon; Triebkorn, Paul; Spiegler, Andreas Frontiers in Computational Neuroscience, Vol. 13 https://doi.org/10.3389/fncom.2019.00054	journal	August 2019
Mathematical Modeling of Protein Misfolding Mechanisms in Neurological Diseases: A Historical Overview Carbonell, Felix; Iturria-Medina, Yasser; Evans, Alan C. Frontiers in Neurology, Vol. 9 https://doi.org/10.3389/fneur.2018.00037	journal	February 2018
On the Influence of Amplitude on the Connectivity between Phases Daffertshofer, Andreas; van Wijk, Bernadette C. M. Frontiers in Neuroinformatics, Vol. 5 https://doi.org/10.3389/fninf.2011.00006	journal	January 2011
101 Labeled Brain Images and a Consistent Human Cortical Labeling Protocol Klein, Arno; Tourville, Jason Frontiers in Neuroscience, Vol. 6 https://doi.org/10.3389/fnins.2012.00171	journal	January 2012
Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment Skene, Nathan G.; Grant, Seth G. N. Frontiers in Neuroscience, Vol. 10 https://doi.org/10.3389/fnins.2016.00016	journal	January 2016
Gradual Disturbances of the Amplitude of Low-Frequency Fluctuations (ALFF) and Fractional ALFF in Alzheimer Spectrum Yang, Liu; Yan, Yan; Wang, Yonghao Frontiers in Neuroscience, Vol. 12 https://doi.org/10.3389/fnins.2018.00975	journal	December 2018
GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment Xu, Yilan; Zhao, Manna; Han, Yuying Frontiers in Neuroscience, Vol. 14 https://doi.org/10.3389/fnins.2020.00660	journal	June 2020
Alzheimer’s Retinopathy: Seeing Disease in the Eyes Mirzaei, Nazanin; Shi, Haoshen; Oviatt, Mia Frontiers in Neuroscience, Vol. 14 https://doi.org/10.3389/fnins.2020.00921	journal	September 2020
Evaluating Effects of Glatiramer Acetate Treatment on Amyloid Deposition and Tau Phosphorylation in the 3xTg Mouse Model of Alzheimer’s Disease Dionisio-Santos, Dawling A.; Karaahmet, Berke; Belcher, Elizabeth K. Frontiers in Neuroscience, Vol. 15 https://doi.org/10.3389/fnins.2021.758677	journal	October 2021
Alzheimer’s Disease-Related Genes Identified by Linking Spatial Patterns of Pathology and Gene Expression Mullins, Roger; Kapogiannis, Dimitrios Frontiers in Neuroscience, Vol. 16 https://doi.org/10.3389/fnins.2022.908650	journal	June 2022
Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy? Melchiorri, Daniela; Merlo, Sara; Micallef, Benjamin Frontiers in Pharmacology, Vol. 14 https://doi.org/10.3389/fphar.2023.1196413	journal	June 2023
Computational Analysis of Pathogenetic Pathways in Alzheimer’s Disease and Prediction of Potential Therapeutic Drugs Petralia, Maria Cristina; Mangano, Katia; Quattropani, Maria Catena Brain Sciences, Vol. 12, Issue 7 https://doi.org/10.3390/brainsci12070827	journal	June 2022
The biological pathways of Alzheimer disease: a review Calabrò, Marco; Rinaldi, Carmela AIMS Neuroscience, Vol. 8, Issue 1 https://doi.org/10.3934/Neuroscience.2021005	journal	January 2021
Integrated transcriptomic and neuroimaging brain model decodes biological mechanisms in aging and Alzheimer’s disease Adewale, Quadri; Khan, Ahmed F.; Carbonell, Felix eLife, Vol. 10 https://doi.org/10.7554/eLife.62589	journal	May 2021

Similar Records

Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer's disease.

Journal Article · Fri May 03 20:00:00 EDT 2024 · Communications Biology · OSTI ID:2396865

Tau and β-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging

Journal Article · Wed Mar 22 00:00:00 EDT 2017 · Journal of Neuroscience · OSTI ID:1393136

Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease

Journal Article · Mon Oct 15 00:00:00 EDT 2018 · Biochemical and Biophysical Research Communications · OSTI ID:23134165

Related Subjects

60 APPLIED LIFE SCIENCES
Alzheimer’s disease
amyloid – beta
computational drug repurposing
inflammation
neuronal dysfunctions and alterations
tau and phospho-tau protein
transcriptomics
whole-brain modeling

In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer’s disease

Citation Formats

References (97)

Similar Records

Related Subjects